HIV women's health: A study of gynecological healthcare service utilization in a U.S. urban clinic population

Journal of Women's Health

Volumn 17, Issue 10, 2008, Pages 1609-1614

  Tello, Monique A ^a,c   Yeh, Hsin Chieh ^a,b   Keller, Jean M ^a   Beach, Mary C ^a   Anderson, Jean R ^a   Moore, Richard D ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CD4 LYMPHOCYTE COUNT; DATA ANALYSIS; DEMOGRAPHY; ETHNICITY; FEMALE; GYNECOLOGIC CARE; HEALTH CARE UTILIZATION; HEALTH CENTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; POPULATION RESEARCH; PREDICTOR VARIABLE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RACE; REFERENCE DATABASE; SUBSTANCE ABUSE; UNITED STATES; URBAN AREA; WOMEN'S HEALTH;

ADULT; AMBULATORY CARE FACILITIES; CONFIDENCE INTERVALS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MATERNAL HEALTH SERVICES; MULTIVARIATE ANALYSIS; ODDS RATIO; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; PREGNANCY; SOCIOECONOMIC FACTORS; UNITED STATES; URBAN POPULATION; WOMEN'S HEALTH;

EID: 57349164528     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2008.0881     Document Type: Article

References (42)

1. Centers for Disease Control and Prevention (CDC) Divisions of HIV/AIDS Prevention. HIV/AIDS among women. Department of Health and Human Services, June 2007. Available at www.cdc.gov/hiv/topics/women/resources/factsheets/women. htm
2. Maryland Department of Health and Mental Hygiene (MDHMH) AIDS Administration. 2005 HIV/AIDS annual report. Available at www.dhmh.state.md. us/AIDS/Data&Statistics/statistics.htm
3. Frankel RE, Selwyn PA, Mezger J, Andrews S. High prevalence of gynecologic disease among hospitalized women with human immunodeficiency virus infection. Clin Infect Dis 1997;25:706-712.
4. Korn AP. Gynecologic care of women infected with HIV. Clin Obstet Gynecol 2001;44:226-242.
5. Cejtin HE. Gynecologic issues in the HIV-infected woman. Obstet Gynecol Clin North Am 2003;30:711-729.
6. Jamieson DJ, Paramsothy P, Cu-Uvin S, Duerr A. Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for HIV. Obstet Gynecol 2006;107:1023-1028.
7. Uphold CR, Mkanta WN. Review: Use of health care services among persons living with HIV infection: State of the science and future directions. AIDS Patient Care STDs 2005;19:473-485.
8. Lachance JA, Everett EN, Greer B, et al. The effect of age on clinical/ pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol Oncol 2006;101:470-475.
9. Gichangi P, De Vuyst H, Estambale B, et al. HIV and cervical cancer in Kenya. Int J Gynecol Obstet 2002;76:55-63.
10. Smith RA, Saslow D, Sawyer KA, et al. American Cancer Society screening guidelines for breast cancer screening: Update 2003. CA Cancer J Clin 2003;53:141-169.
11. Minkoff HL, Eisenberger-Matityahu D, Feldman J, Burk R, Clark L. Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus. Am J Obstet Gynecol 1999;180:824-836.
12. Ellerbrock TV, Chiasson MA, Bush TJ, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000;283:1031-1037.
13. Stein MD, Cunningham WE, Nakazono T, et al. HCSUS Consortium: Screening for cervical cancer in HIV-infected women receiving care in the United States. J AIDS 2001;27:463-466.
14. Maiman M, Fruchter RG, Sedlis A, et al. Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Gynecol Oncol 1998;68:233-239.
15. Anderson JR, Paramsothy P, Heilig C, et al. HIV Epidemiology Research (HER) Study Group: Accuracy of Papanicolaou test among HIV-infected women. Clin Infect Dis 2006;42:562-568.
16. Duerr A, Paramsothy P, Heilig C, et al. HIV Epidemiology Research Study: Effect of HIV infection on atypical squamous cells of undetermined significance. Clin Infect Dis 2006;42:855-861.
17. Lillo FB, Ferrari D, Veglia F, et al. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: Effect of highly active antiretroviral therapy. J Infect Dis 2001;184:547-551.
18. Minkoff HL, Ahdieh L, Massad LS, et al. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS 2001;15:2157-2164.
19. Keiser O, Tejada BM, Wunder D, et al. Frequency of gynecologic follow-up and cervical cancer screening in the Swiss HIV Cohort Study. J AIDS 2006;43:550-555.
20. Solomon L, Stein M, Flynn C, et al. Health services use by urban women with or at risk for HIV-1 infection: The HERS Study. J AIDS 1998;17:253-261.
21. Cejtin HE, Komaroff E, Massad LS, et al. Adherence to colposcopy among women with HIV infection. J AIDS 1999;22:247-258.
22. Baltimore City Health Department. Ryan White Title I Office Quality Improvement Program Primary Health Care Review 2006 - Data presented January 2007.
23. National Institutes of Health Consensus Development Panel. Cervical cancer. NIH Consensus Statement 1996;14:1-38.
24. Benard VB, Lawson HW, Eheman CR, Anderson C, Helsel W. Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women. Obstet Gynecol 2005;105:1323-1328.
25. Jennings-Dozier K. Perceptual determinants of Pap test up-to-date status among minority women. Oncol Nurs Forum 1999;26:1327-1333.
26. Bazargan M, Bazargan SH, Farooq M, Baker RS. Correlates of cervical cancer screening among underserved Hispanic and African-American women. Prev Med 2004;39:465-473.
27. Owusu G, Eve S, Cready C, et al. Race and ethnic disparities in cervical cancer screening in a safety-net system. Matern Child Health J 2005;9:285-295.
28. Heckman TG, Somlai AM, Peters J, et al. Barriers to care among persons living with HIV/AIDS in urban and rural areas. AIDS Care 1998;10:365-375.
29. Cohen MH, Cook JA, Grey D, et al. Medically eligible women who do not use HAART: The importance of abuse, drug use, and race. Am J Public Health 2004;94:1147-1151.
30. Andersen M, Tinsley J, Milfort D, et al. HIV health care access issues for women living with HIV, mental illness, and substance abuse. AIDS Patient Care STDs 2005;19:449-459.
31. Hicks PL, Mulvey KP, Chander G, et al. The impact of illicit drug use and substance abuse treatment on adherence to HAART. AIDS Care 2007;19:1134-1140.
32. Hinkin CH, Barclay TR, Castellon SA, et al. Drug use and medication adherence among HIV-infected individuals. AIDS Behav 2007;11:185-194.
33. Wyatt GE, Carmona JV, Loeb TB, Williams JK. HIV-positive black women with histories of childhood sexual abuse: Patterns of substance use and barriers to health care. J Health Care Poor Underserved 2005;16:9-23.
34. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States. JAMA 1999;281:2305-2315.
35. Ojikutu BO, Stone V. Women, inequality, and the burden of HIV. N Engl J Med 2007;352:649-652.
36. Cunningham WE, Andersen RM, Katz MH, et al. The impact of competing subsistence needs and barriers to access to medical care for persons with HIV receiving care in the United States. Med Care 1999;37:1270-1281.
37. Schuster MA, Collins R, Cunningham WE, et al. Perceived discrimination in clinical care in a nationally representative sample of HIV-infected adults receiving health care. J Gen Intern Med 2005;20:807-813.
38. Beach MC, Keruly J, Moore R. Is the quality of the patient-provider relationship associated with better adherence and outcomes for patients with HIV? J Gen Intern Med 2006;21:661-665.
39. Fuertes J, Mislowack A, Bennet J, et al. The physician-patient working alliance. Patient Educ Couns 2007;66:9-36.
40. Austin L, Ahmad F, McNally M, et al. Breast and cervical cancer screening in Hispanic women: A literature review using the Health Belief Model. Womens Health Issues 2002;12:122-128.
41. Byrd T, Chavez R, Wilson K. Barriers and facilitators of cervical cancer screening among Hispanic women. Ethn Dis 2007;17:129-134.
42. Burak L, Myer M. Using the Health Belief Model to examine and predict college women's cervical cancer screening beliefs and behavior. Health Care Women Int 1997;18:251-662.